Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.

Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Abstract Text:

    gordon w wongGordon W Wong,kerrin l palazzi-churasKerrin L Palazzi-Churas,david f jarrardDavid F Jarrard,david r paoloneDavid R Paolone,andrew k grafAndrew K Graf,sean p hedicanSean P Hedican,john d wegenkeJohn D Wegenke,mark a ritterMark A Ritter,gordon w wongGordon W Wong,kerrin l palazzi-churasKerrin L Palazzi-Churas,david f jarrardDavid F Jarrard,david r paoloneDavid R Paolone,andrew k grafAndrew K Graf,sean p hedicanSean P Hedican,john d wegenkeJohn D Wegenke,mark a ritterMark A Ritter,

    PURPOSE: To evaluate whether hypofractionation is well tolerated and to preliminarily assess biochemical control of this regimen in a postprostatectomy, salvage setting. METHODS AND MATERIALS: A retrospective analysis was performed in 50 patients treated between May 2003 and December 2005 with hypofractionated radiotherapy for biochemical recurrence after radical prostatectomy. Radiotherapy was prescribed to the prostatic fossa to 65-70 Gy in 26-28 fractions of 2.5 Gy each, using intensity-modulated radiotherapy with daily image localization. Toxicities were scored using a modified Radiation Therapy Oncology Group scale and the Fox Chase modification of Late Effects Normal Tissue scale. The median follow-up was 18.9 months (range, 5.3-35.9). RESULTS: No Grade 3 or greater acute or late toxicities were observed. Grade 2 toxicities included four acute genitourinary, one acute gastrointestinal, two late genitourinary, and two late gastrointestinal toxicities. Of the 50 patients, 39 demonstrated a continuous biochemical response after salvage therapy, 3 had an initial response before prostate-specific antigen failure, and 7 had prostate-specific antigen progression, 1 of whom died of progressive metastatic disease. Finally, 1 patient discontinued therapy because of the diagnosis of a metachronous pancreatic cancer and died without additional prostate cancer follow-up. All remaining patients were alive at the last follow-up visit. A lower presalvage prostate-specific antigen level was the only significant prognostic factor for improved biochemical control. The estimated actuarial biochemical control rate at 2 years was 72.9%. CONCLUSIONS: The toxicity and early biochemical response rates were consistent with expectations from conventional fractionation. Additional follow-up is required to better document the biochemical control, but these results suggest that hypofractionation is a well-tolerated approach for salvage radiotherapy.

    Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Publishing Authors By Initials

    gw wongGW Wong,kl palazzi-churasKL Palazzi-Churas,df jarrardDF Jarrard,dr paoloneDR Paolone,ak grafAK Graf,sp hedicanSP Hedican,jd wegenkeJD Wegenke,ma ritterMA Ritter,gw wongGW Wong,kl palazzi-churasKL Palazzi-Churas,df jarrardDF Jarrard,dr paoloneDR Paolone,ak grafAK Graf,sp hedicanSP Hedican,jd wegenkeJD Wegenke,ma ritterMA Ritter,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of radiation oncology, biolo

    VOLUME: 70

    Page Numbers: 449-55

    Journal Abbreviation: Int. J. Radiat. Oncol. Biol. P

    ISSN: 0360-3016

    DAY: 14

    MONTH: 09

    YEAR: 2007

    Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7603616

    Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.

    AFFILIATION: Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Radiat Oncol Biol Phys

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News